Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2025-12-25 @ 12:26 AM
NCT ID:
NCT02491658
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of stable psoriasis vulgaris for at least 6 months
* Baseline Psoriasis Area and Severity Index (PASI) score \>= 8
* Despite systemic or topical treatment, psoriasis is still in active or recurrent condition
* No other psoriasis management (topical or systemic) during the UC-MSCs infusions
* Willing and able to comply with all study requirements and provide informed consent
Exclusion Criteria:
* Other types of psoriasis, such as pustular psoriasis, psoriatic arthritis
* With other disease
* Systemic treatments within 4 weeks before the baseline visit
* Topical treatment within 2 weeks before the baseline visit
* Uncontrolled active infections
* Evidence of infection with Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), or Human Immunodeficiency Virus (HIV)
* History of severe systemic disease or malignancy
* Pregnant or lactating females, or willing to have a baby in the next year
* Cannot be traced on time
* Any other situations not suitable for this study determined by the investigators
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02491658
Study Brief:
Protocol Section:
NCT02491658